二氢嘧啶脱氢酶在大肠癌的表达及其与5-氟尿嘧啶化疗敏感性的研究
摘要
本研究通过免疫组织化学检测大肠癌中二氢嘧啶脱氢酶(DPD)的表达情况,结合体外药敏试验,探讨DPD表达水平与5-氟尿嘧啶(5-FU)化疗敏感性的相关性,从中分析药物代谢相关酶的表达情况,为临床开展耐药指标筛查,指导大肠癌个体化疗提供理论依据。
出处
《中国药物与临床》
CAS
2013年第5期587-589,共3页
Chinese Remedies & Clinics
参考文献2
-
1王华,吴晓江,步召德,董培德,侯明星,季加孚.进展期胃癌术后化疗效果与5-氟尿嘧啶通道基因的关系[J].肿瘤研究与临床,2011,23(6):400-402. 被引量:2
-
2Ikuko Miyazaki,Takashi Kawai,Youji Harada,Fuminori Moriyasu.A predictive factor for the response to S-1 plus cisplatin in gastric cancer[J].World Journal of Gastroenterology,2010,16(36):4575-4582. 被引量:8
二级参考文献25
-
1Dong Hua Zhao-Hui Huang Yong Mao Jian-Zhong Deng.Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouraci-based adjuvant chemotherapy for gastric cancer[J].World Journal of Gastroenterology,2007,13(37):5030-5034. 被引量:10
-
2Japanese Gastric Cancer Association.Japanese Classification of Gastric Carcinoma – 2nd English Edition – Response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria[J]. Gastric Cancer . 2001 (1)
-
3Beck A,,Etienne MC,Chéradame S,Fischel JL,Formento P,Renée N,Milano G.A role for dihydropyrimidine dehydro- genase and thymidylate synthase in tumour sensitivity to ?uorouracil. European Journal of Cancer . 1994
-
4Etienne MC,Chéradame S,Fischel JL,Formento P,Dasson- ville O,Renée N,Schneider M,Thyss A,Demard F,Milano G.Response to?uorouracil therapy in cancer patients:the role of tumoral dihydropyrimidine dehydrogenase activity. Journal of Clinical Oncology . 1995
-
5Ishikawa Y,Kubota T,Otani Y,Watanabe M,Teramoto T,Kumai K,Kitajima M,Takechi T,Okabe H,Fukushima M.Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-?uoro- uracil on human tumor xenografts in nude mice. Clinical Cancer Research . 1999
-
6Ususyo N,Yoshida M,Akimoto S,Yano K,Fujiwara R,Yautida S,Hagiike M,Deishi K,Aida F,Okada S,Maeda H.Prediction of effects and side effects of?uoropyrimidine ad- ministered for gastric cancers and criteria of drug selection. Jpn J Cancer Clin . 2004
-
7Kurebayashi J,Yamamoto Y,Udagawa K,Okubo S,Fuku- shima M,Sonoo H.Establishment of enzyme-linked immu- nosorbent assays for thymidylate synthase and dihydropy- riminide dehydrogenase in cancer tissues. Oncology Reports . 2004
-
8Ichikawa W,Takahashi T,Sudo K,Mituyoshi S,Yamashita T,Sirota Y,Nihei Y,Hirayama K.Predictive values of thymi- dine synthase and dehydropyrimidine dehydrogenase gene expression in gastric cancer patients treated with S-1 based chemotherapy. Jpn J Cancer Clin . 2003
-
9Meropol NJ,Gold PJ,Diasio RB,Andria M,Dhami M,Godfrey T,Kovatich AJ,Lund KA,Mitchell E,Schwarting R.Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients withmetastatic colorectal cancer. Journal of Clinical Oncology . 2006
-
10Fukui Y,,Oka T,Nagayama S,Danenberg PV,Danenberg KD,Fukushima M.Thymidylate synthase,dihydropyrimi- dine dehydrogenase,orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. International Journal of Molecular Medicine . 2008
共引文献8
-
1王晓瑜,甘润良.胃癌相关基因的功能和作用[J].医学综述,2012,18(6):854-858. 被引量:4
-
2张逸寅,顾康生.胃癌常用化疗药物敏感性标志物研究进展[J].国际肿瘤学杂志,2013,40(1):61-64.
-
3王吉恒,张占东,孔烨,马飞,花亚伟.胃癌相关基因的研究进展[J].河南医学研究,2013,22(1):147-150. 被引量:5
-
4陈英华,傅建伟,邓媛,廖毅,黄薇,王丁琼.晚期胃癌患者外周血中TS和DPD mRNA的表达对替吉奥化疗疗效的影响[J].重庆医学,2013,42(12):1357-1359. 被引量:6
-
5武月,赵葳,闫兆鹏,曹献馗,苏琪.TS、DPD与5-FU的关系及在消化道肿瘤个体化治疗中的意义[J].现代肿瘤医学,2013,21(7):1656-1659. 被引量:4
-
6练炼,慎晓明,周冲,陶敏.胃癌患者血清DPD mRNA和TS mRNA表达对替吉奥疗效预测价值分析[J].中华肿瘤防治杂志,2015,22(5):368-372. 被引量:4
-
7张丹,陈妍妍.TS水平在晚期胃癌患者中对替吉奥化疗疗效的影响[J].中国医药科学,2016,6(12):166-168. 被引量:3
-
8郑积华.TS和DPD mRNA对替吉奥治疗晚期胃癌的疗效预测[J].实用癌症杂志,2014,29(7):789-790. 被引量:2
-
1鲁明骞,徐光川.二氢嘧啶脱氢酶在胃癌中的研究现状[J].世界华人消化杂志,2006,14(34):3290-3293. 被引量:2
-
2宁连胜,刘磊,郎义方,马淑资,李云英,石松魁,于冬,方志沂,惠锐,侯子正,毛慧生,孙慧,赵文华,王垣,李丽庆,张万岭,赵宝林,王文治,韩来声,刘长君,张天泽.晚期乳腺癌的个体化疗[J].中国肿瘤临床,1990,17(5):287-289.
-
3蔡乐,朱珠.二氢嘧啶脱氢酶及其与5-氟尿嘧啶疗效和毒性的关系[J].中国药学杂志,2007,42(19):1441-1445. 被引量:7
-
4李伟平,叶怀庄.高效液相色谱法测定胃癌患者5-氟尿嘧啶血药浓度[J].浙江预防医学,2006,18(6).
-
5王晓云,文思远,胡小电,王升启.5-氟尿嘧啶的毒副作用与二氢嘧啶脱氢酶基因多态性关系的研究进展[J].国外医学(药学分册),2003,30(3):178-181. 被引量:3
-
6董秋美,郑伟华,张鹏,何友兼,沙丹.检测结直肠癌患者二氢嘧啶脱氢酶的意义[J].广东医学,2006,27(9):1309-1311.
-
7刘宇,戚苏明,王浦海,丁逸梅.二氢嘧啶脱氢酶抑制剂吉美拉西的合成[J].华西药学杂志,2008,23(3):252-254. 被引量:1
-
8李倩玉,王一.恶性肿瘤化疗耐药评价体系的研究进展[J].国外医学(肿瘤学分册),2005,32(5):355-358. 被引量:1
-
9王磊,胡冰.二氢嘧啶脱氢酶在结直肠癌中的研究现状及进展[J].安徽医药,2010,14(4):373-375. 被引量:3
-
10周甘平,周婷,周舍典,吴光樑,卓仁恭,徐峰.抑郁心境对恶性肿瘤患者二氢嘧啶脱氢酶水平的影响[J].今日药学,2010,20(4):10-12. 被引量:5